Valuation: Phaarmasia Limited

Market Cap 601M 6.35M 5.67M 5.2M 4.73M 8.87M 9.04M 62.09M 25.03M 317M 23.81M 23.31M 1B P/E 2025
-12.6x
P/E 2026 2.92x
Enterprise Value 504M 5.32M 4.75M 4.36M 3.97M 7.43M 7.58M 52.07M 20.99M 266M 19.97M 19.54M 840M EV / Sales 2025
0.81x
EV / Sales 2026 0.88x
Free-Float
-
Yield 2025 *
-
Yield 2026 -
1 day+0.01%
1 week+6.02%
Current month+9.86%
1 month-4.76%
3 months+0.34%
6 months-10.35%
Current year-21.94%
1 week 79
Extreme 79
89
1 month 75.1
Extreme 75.1
96.75
Current year 67
Extreme 67
131.75
1 year 30.6
Extreme 30.6
131.75
3 years 23.6
Extreme 23.6
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 2016-02-11
Compliance Officer - 2020-01-02
Director TitleAgeSince
Chairman 71 2010-10-13
Director/Board Member 55 2012-12-08
Director/Board Member 63 2012-12-18
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%+6.02%+151.72%+235.88% 6.35M
-0.46%+10.31%+63.52%+143.15% 1,257B
-0.97%+1.60%+43.25%+80.09% 651B
-2.05%+0.73%+32.47%+101.62% 510B
-1.54%+0.18%+53.42%+66.79% 388B
-0.78%+5.51%+72.55%+44.25% 366B
-1.69%+3.17%+32.49%+55.35% 303B
-0.72%+7.83%+11.15%+33.76% 288B
-0.12%+4.68%+55.97%+74.59% 252B
-0.21%+7.34%+42.19%+109.69% 211B
Average -0.79%+3.37%+55.87%+94.52% 422.67B
Weighted average by Cap. -0.73%+5.69%+49.19%+93.33%

Financials

2025 2026
Net sales 244M 2.57M 2.3M 2.11M 1.92M 3.6M 3.67M 25.19M 10.15M 129M 9.66M 9.45M 406M 472M 4.99M 4.45M 4.09M 3.72M 6.97M 7.11M 48.8M 19.67M 249M 18.71M 18.32M 787M
Net income -15.89M -168K -150K -138K -125K -235K -239K -1.64M -662K -8.39M -630K -617K -26.5M 176M 1.86M 1.66M 1.52M 1.38M 2.59M 2.65M 18.16M 7.32M 92.75M 6.97M 6.82M 293M
Net Debt -1.94M -20.46K -18.27K -16.76K -15.25K -28.59K -29.16K -200K -80.71K -1.02M -76.79K -75.15K -3.23M -96.98M -1.02M -915K -839K -763K -1.43M -1.46M -10.02M -4.04M -51.19M -3.84M -3.76M -162M
Projected Income Statement - Annual - Phaarmasia Limited
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
47
Date Price Change Volume
26-11-03 ₹88.00 +0.01% 199
26-11-02 ₹87.99 +9.85% 995
26-10-30 ₹80.10 -10.00% 7
26-10-29 ₹89.00 +7.23% 323
26-10-28 ₹83.00 0.00% 7
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock